Davis JM - Search Results

1

The response of subgroups of patients with schizophrenia to different antipsychotic drugs: a systematic review and meta-analysis.

Leucht S, Chaimani A, Krause M, Schneider-Thoma J, Wang D, Dong S, Samara M, Peter N, Huhn M, Priller J, Davis JM. Leucht S, et al. Among authors: davis jm. Lancet Psychiatry. 2022 Nov;9(11):884-893. doi: 10.1016/S2215-0366(22)00304-2. Epub 2022 Oct 10. Lancet Psychiatry. 2022. PMID: 36228647

2

CSF and plasma MHPG, and CSF MHPG index: pretreatment levels in diagnostic groups and response to somatic treatments.

Sharma RP, Javaid JI, Faull K, Davis JM, Janicak PG. Sharma RP, et al. Among authors: davis jm. Psychiatry Res. 1994 Jan;51(1):51-60. doi: 10.1016/0165-1781(94)90046-9. Psychiatry Res. 1994. PMID: 7910975

3

Cerebrospinal fluid somatostatin concentrations in schizophrenia and schizoaffective disorder: the effects of antipsychotic treatment.

Sharma RP, Bissette G, Janicak P, Davis JM, Nemeroff CB. Sharma RP, et al. Among authors: davis jm. Schizophr Res. 1994 Sep;13(2):173-7. doi: 10.1016/0920-9964(94)90099-x. Schizophr Res. 1994. PMID: 7986775

4

Dose response of prophylactic antipsychotics.

Davis JM, Kane JM, Marder SR, Brauzer B, Gierl B, Schooler N, Casey DE, Hassan M. Davis JM, et al. J Clin Psychiatry. 1993 Mar;54 Suppl:24-30. J Clin Psychiatry. 1993. PMID: 8097195 Review.

5

Homovanillic acid in the cerebrospinal fluid: patterns of response after four weeks of neuroleptic treatment.

Sharma RP, Javaid JI, Janicak PG, Davis JM, Faull K. Sharma RP, et al. Among authors: davis jm. Biol Psychiatry. 1993 Aug 1;34(3):128-34. doi: 10.1016/0006-3223(93)90381-m. Biol Psychiatry. 1993. PMID: 8104508

6

Platelet serotonin-2 receptors in schizophrenia: effects of illness and neuroleptic treatment.

Pandey SC, Sharma RP, Janicak PG, Marks RC, Davis JM, Pandey GN. Pandey SC, et al. Among authors: davis jm. Psychiatry Res. 1993 Jul;48(1):57-68. doi: 10.1016/0165-1781(93)90113-u. Psychiatry Res. 1993. PMID: 8105499

7

Elevation of CSF somatostatin concentrations in mania.

Sharma RP, Bissette G, Janicak PG, Davis JM, Nemeroff CB. Sharma RP, et al. Among authors: davis jm. Am J Psychiatry. 1995 Dec;152(12):1807-9. doi: 10.1176/ajp.152.12.1807. Am J Psychiatry. 1995. PMID: 8526251

8

Antipsychotic dosing strategies in acute schizophrenia.

Janicak PG, Davis JM. Janicak PG, et al. Among authors: davis jm. Int Clin Psychopharmacol. 1996 May;11 Suppl 2:35-40. doi: 10.1097/00004850-199605002-00006. Int Clin Psychopharmacol. 1996. PMID: 8803658 Review.

9

Pretreatment plasma homovanillic acid in schizophrenia and schizoaffective disorder: the influence of demographic variables and the inpatient drug-free period.

Sharma RP, Javaid JI, Davis JM, Janicak PG. Sharma RP, et al. Among authors: davis jm. Biol Psychiatry. 1998 Sep 15;44(6):488-92. doi: 10.1016/s0006-3223(97)00451-4. Biol Psychiatry. 1998. PMID: 9777181 Clinical Trial.

10

The effects of olanzapine on the 5 dimensions of schizophrenia derived by factor analysis: combined results of the North American and international trials.

Davis JM, Chen N. Davis JM, et al. J Clin Psychiatry. 2001 Oct;62(10):757-71. doi: 10.4088/jcp.v62n1003. J Clin Psychiatry. 2001. PMID: 11816864

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,107 results

Search Page